Valuation check: AIMD's profit margin is -769.96%, below the Healthcare sector average of 15.52%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
The latest profit margin for AIMD is -769.96% as of March 2026. That compares with -139.67% in the prior-year period — down 451.3% year over year. That is below the Healthcare sector average of 15.52%. Investors often review this figure alongside Ainos's historical trend and sector peers before judging valuation or financial health.
Over the past year, AIMD's profit margin moved from -139.67% to -769.96% — a 451.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Ainos's valuation or profitability profile.
Against Healthcare companies, AIMD currently prints -769.96% for profit margin, while the sector average sits near 15.52%. That is roughly 496203.2% below the sector mean. Large gaps often invite a closer look at Ainos's growth, margins, and balance sheet.
Profit Margin shows how effectively Ainos converts resources into returns. At -769.96%, AIMD may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -139.67% in the prior-year period — down 451.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting AIMD's profit margin (-769.96%), review year-over-year change from -139.67%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.